|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
What are the current challenges to wider biosimilar use in the United States?
Plain Language Summary
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Changing Tumor Classifications May Explain Rise in Early-Onset CRC
2
Medicaid Work Requirements Set to Leave Millions Without Insurance
3
Remote Physiological Monitoring Improves Patient Access, Care, and Revenue
4
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
5












































